FDA Updates Propecia Labels
The U.S. Food and Drug Administration (FDA) announced that the labels for Merck & Co.’s male baldness drugPropeciaand enlarged prostate therapy Proscar will be updated to warn of their link to sexual dysfunction even after drug use has ceased. The FDA said Propecia ’s label will include warnings about orgasm, libido, and ejaculation disorders that may occur even after patients stop using the drugs, according to Bloomberg